S-606001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-606001, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD) [Phase 2]